Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Billing Codes

HCPCS code K0553: CGM supply allowance, deletion, and replacement codes

Avatar photo Maja Popovska
Last Updated: August 19, 2026
Key takeaways

Key takeaways

HCPCS code K0553 covered the monthly supply allowance for a therapeutic, non-adjunctive, non-implanted CGM under the Medicare Part B DME benefit. CMS discontinued it effective 12/31/2022.

For dates of service on or after 1/1/2023, bill E2103 for the non-adjunctive monitor or receiver and A4239 for the monthly supply allowance.

E2103 is the non-adjunctive code, not an adjunctive one. Adjunctive devices use a separate set, E2102 for the monitor and A4238 for supplies, and both require the KF modifier.

K0554, the dedicated receiver code for therapeutic CGM systems, was discontinued alongside K0553. It is deleted, not active, and E2103 replaced it.

Only enrolled DMEPOS suppliers may bill CGM supply allowances. A written order from the treating practitioner and a supporting diabetes diagnosis code are required on every claim.

Pabau’s claims management software helps DMEPOS billing teams track active HCPCS codes, flag deleted codes before submission, and maintain compliant documentation records.

HCPCS code K0553 described a monthly supply allowance for a therapeutic continuous glucose monitor (CGM) that was non-adjunctive and non-implanted. The code bundled every supply and accessory into a single monthly billing unit, where one unit of service equaled one month of supply. CMS discontinued K0553 effective December 31, 2022.

Field Detail
HCPCS Code K0553
Long Description Supply allowance for therapeutic continuous glucose monitor (CGM) device, non-adjunctive, non-implanted; includes all supplies and accessories, 1 month supply = 1 unit of service
Short Descriptor Sply alw nonadjunc nonimpl cgm 1 mo sply 1 uos
Code Status Deleted / inactive
Deletion Effective Date Discontinued effective 12/31/2022 (last valid date of service)
Code Type HCPCS Level II (DME supply)
Primary Payer Medicare Part B (DME benefit)
Unit of Service 1 unit = 1 month supply
Replacement Codes E2103 (non-adjunctive CGM or receiver) plus A4239 (monthly supply allowance), for dates of service on or after 1/1/2023
Companion Deleted Code K0554, dedicated receiver for therapeutic CGM systems, also deleted effective 12/31/2022

The code fell under the K-series of HCPCS Level II, which CMS uses for DME items not classified elsewhere. While K0553 was active, only enrolled DMEPOS suppliers could submit claims under it. The CMS HCPCS program maintains the Level II code set and publishes quarterly updates that include additions, revisions, and deletions.

Why K0553 was deleted and what replaced it

CMS restructured CGM supply coding to separate therapeutic (non-adjunctive) devices from adjunctive ones. A non-adjunctive CGM is FDA-cleared for insulin dosing without a confirmatory fingerstick, which changes its coverage classification under the Medicare Part B DME benefit. The K-series codes did not carry that distinction, so CMS retired them and issued replacements in the A and E series.

K0553 did not go alone. Its companion code K0554, “Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system,” was discontinued on the same date. Both described therapeutic, non-adjunctive equipment, and neither ever applied to an adjunctive device.

The transition runs on dates of service, not submission dates. K0553 and K0554 are valid only for dates of service through December 31, 2022. For dates of service on or after January 1, 2023, suppliers bill E2103 and A4239 instead.

Claims that still carry K0553 are denied automatically. There is no appeal pathway for a code CMS has discontinued, so the fix is a code-master update rather than a redetermination request.

Choosing the right replacement depends on two variables. The first is whether the device is adjunctive or non-adjunctive. The second is whether you are billing the monitor itself or the monthly supplies. The table below maps each scenario to the correct active code. Descriptors come from the CMS HCPCS file and the DME MAC Glucose Monitor policy article.

Code Official descriptor Use when Status
E2103 Non-adjunctive, non-implanted continuous glucose monitor or receiver Billing the non-adjunctive CGM or receiver itself. Pair it with A4239 for the monthly supplies. Active
A4239 Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (CGM), includes all supplies and accessories, 1 month supply = 1 unit of service Billing the monthly supplies for a non-adjunctive CGM. One unit covers 30 days. Active
E2102 Adjunctive, non-implanted continuous glucose monitor or receiver The device still needs a fingerstick to confirm a reading before dosing. Add the KF modifier. Active
A4238 Supply allowance for adjunctive, non-implanted continuous glucose monitor (CGM), includes all supplies and accessories, 1 month supply = 1 unit of service Billing the monthly supplies for an adjunctive CGM. Add the KF modifier. Active
A9276 Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply The CGM system does not meet Medicare’s DME definition. This is not a K0553 replacement. Active, but invalid for DME CGM supply billing
K0553 Supply allowance for therapeutic continuous glucose monitor (CGM) device, non-adjunctive, non-implanted Do not use. Bill A4239 for dates of service on or after 1/1/2023. Deleted, last date of service 12/31/2022
K0554 Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system Do not use. Bill E2103 for dates of service on or after 1/1/2023. Deleted, last date of service 12/31/2022

E2103 and A4239 are the non-adjunctive pair, and that is where most former K0553 claims land. Non-adjunctive devices such as the Dexcom G6 and G7 and the FreeStyle Libre 3 are FDA-cleared to replace fingerstick testing for treatment decisions. That clearance is what puts them on the therapeutic CGM coverage pathway under Medicare Part B.

E2102 and A4238 cover the other side. An adjunctive CGM still requires a confirmatory fingerstick before an insulin dose, and the FDA classifies these devices as Class III. Every claim for E2102 or A4238 needs the KF modifier. For systems that fall outside the DME benefit entirely, see our guide to HCPCS code A9278.

Pro Tip

Contact the PDAC (Pricing, Data Analysis and Coding contractor) before you bill any CGM supply code. Do this whenever you are unsure whether the device is adjunctive or non-adjunctive. PDAC issues coding verification letters that protect suppliers from post-payment audits. The CGS Medicare Coding Verification page lists current verification guidance for DME suppliers.

Medicare coverage criteria for CGM supply allowances

Medicare Part B covers therapeutic CGM supplies under the DME benefit, governed by Local Coverage Determination L33822 (Glucose Monitors). Coverage for the active replacement codes, E2103 and A4239, requires all of the following conditions to be met before the first claim is submitted.

  • Diabetes diagnosis: The beneficiary must have a confirmed diabetes mellitus diagnosis. Type 1, Type 2, and secondary diabetes diagnoses all qualify, provided the correct ICD-10-CM code is on the claim.
  • Treating practitioner order: A written, signed, and dated order from the treating practitioner must be on file before billing. Verbal orders do not satisfy this requirement.
  • Device classification: The device must be FDA-cleared as non-adjunctive before you bill E2103 and A4239. Adjunctive devices are billed under E2102 and A4238 with the KF modifier.
  • DMEPOS supplier enrollment: Only suppliers enrolled in the Medicare DMEPOS program may submit claims for CGM supply allowances. Physician offices that dispense CGM supplies directly need to verify their enrollment status with their MAC.
  • Insulin treatment or problematic hypoglycemia: LCD L33822 once required three or more daily insulin administrations. CMS removed that requirement effective April 16, 2023. Coverage now reaches beneficiaries treated with any insulin, plus beneficiaries with a documented history of problematic hypoglycemia.

Practices managing patients with metabolic conditions can find workflow support through metabolic health EMR software built to handle the documentation layers these coverage pathways require. Weight management programs that integrate CGM monitoring should also review the billing requirements specific to weight loss clinic software platforms that support DMEPOS-adjacent documentation.

ICD-10-CM diagnosis codes that support medical necessity

Every CGM supply claim requires a diabetes mellitus ICD-10-CM code that establishes medical necessity. The table below lists commonly used codes. Note that only specific codes are accepted under LCD L33822; submitting an unspecified or unsupported code is a common denial trigger.

ICD-10-CM Code Description Notes
E10.65 Type 1 diabetes mellitus with hyperglycemia Common for insulin-dependent Type 1 patients
E11.65 Type 2 diabetes mellitus with hyperglycemia Document insulin use or problematic hypoglycemia per LCD criteria
E10.649 Type 1 diabetes mellitus with hypoglycemia without coma Supports medical necessity for continuous monitoring
E11.649 Type 2 diabetes mellitus with hypoglycemia without coma Supports medical necessity for continuous monitoring
E13.65 Other specified diabetes mellitus with hyperglycemia Secondary or drug-induced diabetes scenarios

Cross-reference your patient’s specific diabetes code against the CMS HCPCS coverage database and LCD L33822 before submitting. For ICD-10 diagnosis code reference guides across other specialties, using a structured lookup approach prevents the same unspecified-code denial pattern.

Modifiers that apply to E2103 and A4239

Every CGM claim carries at least one modifier, and the DME MACs reject claims that arrive without one. Which modifier you append depends on the beneficiary’s insulin status and on the FDA class of the device.

Modifier Meaning When to append it
KX Requirements specified in the medical policy have been met The beneficiary is insulin-treated. Append it to both E2103 and A4239.
KS Glucose monitor supply for a diabetic beneficiary not treated with insulin The beneficiary is not insulin-treated and qualifies through problematic hypoglycemia.
KF Item designated by the FDA as a Class III device The CGM is FDA Class III. It is mandatory on adjunctive codes E2102 and A4238.
GA or GZ Waiver of liability on file (GA) or no waiver on file (GZ) You expect the claim to be denied as not medically necessary.

KX and KS are mutually exclusive on the same claim line. Pick the one that matches the documented treatment plan, then update it whenever the patient’s insulin status changes. A stale KX on a patient who has come off insulin is a recoupment risk on audit.

Fee schedule and reimbursement for CGM supply allowances

Medicare pays E2103 and A4239 from the DMEPOS fee schedule, not the physician fee schedule. There is no single national rate. Allowables are set by state and jurisdiction, and CMS revises them through quarterly update files.

  • Where the rate comes from: Download the current DMEPOS fee schedule file from CMS and look up E2103 and A4239 for your state. Each quarterly file supersedes the last, so check the effective date.
  • Supply allowance frequency: A4239 is billed as one unit per month. The DME MACs allow up to three units of service per 90 days, which supports a quarterly shipping cycle.
  • Beneficiary cost share: The beneficiary owes 20% of the allowed amount once the Part B deductible is satisfied. Tell patients this before the first shipment goes out.
  • Prior authorization forms: Many Medicare Advantage and Medicaid plans require prior authorization for CGM. Their request forms must now list E2103 or A4239, not K0553 or K0554.

Do not quote a rate from a third-party lookup site. The CMS fee schedule file is the only source that reflects the current quarter, and it is free to download.

Billing guidelines for HCPCS code K0553 (and its replacement codes)

These guidelines applied to K0553 when it was active and continue to apply to its replacement codes. The core billing rules did not change with the restructuring, only the codes themselves.

Documentation requirements

Missing or incomplete documentation is the second most common denial reason after billing a deleted code. The practitioner order and delivery records must be in the supplier’s file before the claim is submitted, not after a denial triggers a records request.

  • Written practitioner order: Must include the patient’s name, date of order, and the specific CGM device or supply type ordered. It also needs frequency of use, the treating practitioner’s signature, and the date signed. Generic or stamped signatures are flagged on audit.
  • Diabetes diagnosis confirmation: The patient’s medical record must document a current, active diabetes diagnosis with the ICD-10-CM code that matches the claim.
  • Proof of delivery: A signed delivery record (or shipping confirmation for mail-order suppliers) dated before or on the claim date of service.
  • DMEPOS enrollment verification: The supplier’s National Provider Identifier (NPI) must be enrolled as a DMEPOS supplier with Medicare. Claims from non-enrolled suppliers are denied at the eligibility check stage.
  • Refill documentation: For monthly supply refills, suppliers must have documented contact with the patient or caregiver confirming the supplies are still needed. CMS requires this for ongoing monthly claims.

Using digital forms for clinical documentation can help DME-adjacent practices build a timestamped, auditable paper trail for every order element listed above. For practices concerned with HIPAA-compliant billing workflows, documentation storage and access controls are equally important in a DMEPOS audit context.

Digital intake and order forms used for DMEPOS documentation
Digital intake and order forms give DMEPOS suppliers a timestamped record of every element a CGM claim has to prove.

Common billing errors and how to avoid them

The Noridian MAC published billing articles specifically on CGM supply coding before K0553 was retired. The denial patterns they identified continue to recur with the replacement codes. Here are the most frequent errors, verified across multiple MAC sources.

  • Billing K0553 or K0554 after 12/31/2022: Both codes were discontinued on that date. Every claim using them for a later date of service is rejected, and there is no appeal pathway. Move your billing system to E2103 and A4239.
  • Incorrect units of service: One unit equals one month of supply. Billing more than one unit for a single calendar month is an overpayment that triggers a recoupment request on audit.
  • Missing DMEPOS enrollment: If your supplier NPI is not enrolled as a DMEPOS supplier, the claim is denied before a human ever reviews it. Enrollment verification should be part of your monthly credentialing check.
  • Billing before delivery: The date of service must match when the supplies were delivered or shipped. It is not the date of the practitioner order.
  • Adjunctive and non-adjunctive mismatch: E2103 and A4239 are the non-adjunctive codes. If the device still requires a fingerstick to confirm a reading before dosing, bill E2102 and A4238 with the KF modifier instead. Confirm the classification with PDAC if you are unsure.
  • Billing the monitor without the supply allowance: E2103 covers the receiver, and A4239 covers the sensors and accessories. Submitting one and forgetting the other leaves part of the episode unpaid.
  • No refill request documentation: Billing monthly refills without documented patient need confirmation is one of the top CGM-specific audit findings. Document every refill contact.

For broader coding reference, the PGM Billing HCPCS lookup tool lets billers verify active code status before submission, helping avoid the deleted-code denial entirely. The medical billing documentation requirements that apply to specialty coding share the same pre-submission verification logic as DMEPOS claims.

HCPCS codes like E2103 and A4239 handle the equipment side of CGM billing. The clinical services associated with CGM, including sensor placement, patient training, and data interpretation, are billed using CPT codes. These are typically billed by the treating physician or practitioner, not the DMEPOS supplier.

CPT Code Description Billed By
95250 Ambulatory CGM of interstitial tissue fluid; physician order and sensor attachment, patient training, sensor removal Treating physician or qualified clinician
95251 Ambulatory CGM of interstitial tissue fluid; interpretation and report, each 24 hours of data Treating physician (interpretation and report required)

CPT 95250 covers the placement, training, and removal service. CPT 95251 covers interpretation of the CGM data, billed per 24-hour period. These are distinct from the HCPCS supply codes and cannot be billed by the DMEPOS supplier in most cases. Practices billing both sides of CGM services need the physician component and the supply component billed by the correct NPI under the correct benefit category.

The ICD-10 coding resources for clinical billing that address multi-code claim construction apply the same separation-of-services logic. For an overview of specialty procedure coding outside the CGM space, CPT coding for specialty healthcare services provides a useful structural reference.

How Pabau supports CGM billing and code compliance

Denial prevention in CGM billing comes down to three things. You need the correct active code, the documentation in place before the claim goes out, and payer-specific requirements checked before submission. Billing teams already know these rules. The failures happen when the system does not enforce them at the point of claim creation.

Practice management software like Pabau gives billing teams a structured environment for this work. Our claims management software tracks claim status, holds documentation checklists against each order, and flags problems before submission. So a deleted code such as K0553 gets caught in your own system rather than by a payer rejection three weeks later.

The Claim.MD integration submits those claims electronically and returns the payer response into the same record. Connecting the clinical note to the billing workflow also shortens the distance between the practitioner order and the supplier claim. That handoff is where CGM documentation usually falls down.

Automated claim submission screen inside Pabau
Automated submission sends each claim to the connected clearinghouse, so a coding error surfaces before the payer denies it.

The practice management software layer ties scheduling, clinical notes, and billing into one auditable workflow. That matters when a practice bills both CPT service codes and DMEPOS supply codes for the same patient population. Recurring monthly CGM claims also benefit from automated prompts for refill confirmation, which is one of the most common CGM audit findings.

Pro Tip

Run a monthly audit of your active HCPCS codes against the CMS quarterly update files. CMS publishes additions, revisions, and deletions four times a year. A deleted code that stays in your billing system is a claim denial waiting to happen. Set a calendar reminder to cross-reference your code master list against each CMS HCPCS quarterly release.

Stop billing denials before they start

Pabau’s claims management tools help DMEPOS billing teams flag deleted HCPCS codes, maintain compliant documentation workflows, and track claim status across payers. See how it works for your practice.

Pabau claims management dashboard

Conclusion

HCPCS code K0553 is no longer billable. CMS discontinued it effective December 31, 2022, along with its companion receiver code K0554. For dates of service on or after January 1, 2023, a non-adjunctive CGM uses two codes. E2103 covers the monitor or receiver, and A4239 covers the monthly supply allowance.

Adjunctive devices are a different code set entirely. Those claims use E2102 for the monitor and A4238 for the supply allowance, and both require the KF modifier. Neither E2103 nor K0554 ever described an adjunctive device.

Getting CGM billing right comes down to three habits. Match the device’s classification to the correct code. Keep a complete order and delivery file before submission, and confirm DMEPOS enrollment for every billing NPI. Pabau’s digital documentation tools help practices build the auditable records that support clean claims from the first submission. To see how Pabau handles claims workflows for DME-adjacent practices, book a demo.

Continue your research

Continue your research

Need to verify active HCPCS code status before billing? Bupa CCSD procedure codes guide covers the parallel billing structure used in UK private healthcare, including how code verification works across different payer systems.

Billing a CGM that falls outside the DME benefit? HCPCS code A9278 explains how external CGM receiver billing works when the system does not meet Medicare’s durable medical equipment definition.

Managing compliance documentation for DME billing? HIPAA Security Rule requirements outlines the documentation retention and access control standards that apply to billing records in a DMEPOS audit context.

Handling multi-code billing across physician and supplier sides? Medical forms for healthcare practices covers how structured intake and order documentation reduces the errors that generate downstream claim denials.

Frequently asked questions

What is HCPCS code K0553?

HCPCS code K0553 was a HCPCS Level II code for the monthly supply allowance for a therapeutic, non-adjunctive, non-implanted continuous glucose monitor (CGM). One unit of service equaled one month of supply. CMS discontinued the code effective December 31, 2022, and claims submitted under it are now denied.

When was HCPCS code K0553 deleted?

K0553 was discontinued effective December 31, 2022, which is its last valid date of service. For dates of service on or after January 1, 2023, suppliers must bill E2103 and A4239 instead. The companion receiver code K0554 was discontinued on the same date.

What replaced HCPCS code K0553?

E2103 and A4239 replaced K0553 for non-adjunctive CGM. E2103 covers the non-adjunctive, non-implanted monitor or receiver, and A4239 covers the monthly supply allowance at one unit per 30 days. Adjunctive devices are billed separately under E2102 and A4238, and both of those codes require the KF modifier.

Is E2103 an adjunctive or a non-adjunctive code?

E2103 is the non-adjunctive code. Its official long descriptor is “Non-adjunctive, non-implanted continuous glucose monitor or receiver,” so it applies to devices cleared for insulin dosing without a confirmatory fingerstick. The adjunctive equivalent is E2102, and its matching supply allowance is A4238.

Is K0554 still an active HCPCS code?

No. K0554 described a dedicated receiver for a therapeutic, meaning non-adjunctive, glucose continuous monitor system. It was discontinued effective December 31, 2022, at the same time as K0553. E2103 is the replacement code for dates of service on or after January 1, 2023.

What is the difference between K0553 and A4239?

A4239 is the active replacement for the deleted K0553. Both codes describe a monthly supply allowance for a non-adjunctive CGM, with one unit of service per month. The functional difference is billability. A4239 is payable for dates of service on or after January 1, 2023, and K0553 is not payable at all.

Does Medicare cover CGM supplies under K0553?

Medicare no longer covers claims billed under K0553 because the code was discontinued on December 31, 2022. Part B covers CGM under E2103 and A4239 through the DME benefit, subject to LCD L33822 criteria. Those criteria include a diabetes diagnosis, a written practitioner order, non-adjunctive device classification, and DMEPOS supplier enrollment.

What is a non-adjunctive CGM device?

A non-adjunctive CGM is an FDA-cleared device that patients can use to make insulin dosing decisions without a confirmatory fingerstick blood glucose test. Devices like the Dexcom G6, G7, and FreeStyle Libre 3 meet this classification. Adjunctive CGMs still require a fingerstick to confirm readings before an insulin dose.

×